| 产品编号 | 结构式 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A666751 |
| Anti-B7-H3 & EGFR Reference Antibody (Ibi-334), Target:B7-H3&EGFR,Uniprot:Q5ZPR3&P00533,Species:Human,isotype:IgG-like Anti-B7-H3 & EGFR Reference Antibody (Ibi-334), Target:B7-H3&EGFR,Uniprot:Q5ZPR3&P00533,Species:Human,isotype:IgG-like |
||
| A666750 |
| Anti-IL-17 & TNF-alpha Reference Antibody (COVA322), Target:IL-17&TNF-alpha,Uniprot:Q16552-1&P01375,Species:Human,isotype:IgG-VHH Anti-IL-17 & TNF-alpha Reference Antibody (COVA322), Target:IL-17&TNF-alpha,Uniprot:Q16552-1&P01375,Species:Human,isotype:IgG-VHH |
||
| A666749 |
| Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig), Target:LAG-3&PD-1,Uniprot:P18627&Q15116,Species:Human,isotype:IgG-like Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig), Target:LAG-3&PD-1,Uniprot:P18627&Q15116,Species:Human,isotype:IgG-like |
||
| A666748 |
| Anti-CD20 & CD3 Reference Antibody (Odronextamab), Target:CD20&CD3,Uniprot:P11836&P07766,Species:Human,isotype:IgG-like Anti-CD20 & CD3 Reference Antibody (Odronextamab), Target:CD20&CD3,Uniprot:P11836&P07766,Species:Human,isotype:IgG-like |
||
| A666747 |
| Anti-TNF-alpha Reference Antibody (Ozoralizumab), Target:TNF-alpha,Uniprot:P01375,Species:Human,isotype:VHH-VHH-VHH Anti-TNF-alpha Reference Antibody (Ozoralizumab), Target:TNF-alpha,Uniprot:P01375,Species:Human,isotype:VHH-VHH-VHH |
||
| A666746 |
| Anti-B7-H4 & CD3 Reference Antibody (Gen1047), Target:B7-H4&CD3,Uniprot:Q7Z7D3&P07766,Species:Human,isotype:IgG-like Anti-B7-H4 & CD3 Reference Antibody (Gen1047), Target:B7-H4&CD3,Uniprot:Q7Z7D3&P07766,Species:Human,isotype:IgG-like |
||
| A666745 |
| Anti-cMet & EGFR Reference Antibody (Amivantamab), Target:cMet&EGFR,Uniprot:P08581&P00533,Species:Human,isotype:IgG-like Anti-cMet & EGFR Reference Antibody (Amivantamab), Target:cMet&EGFR,Uniprot:P08581&P00533,Species:Human,isotype:IgG-like |
||
| A666744 |
| Anti-EGFR & Fc-gamma-RIIIA Reference Antibody (AFM24), Target:EGFR&Fc-gamma-RIIIA,Uniprot:P00533&P08637,Species:Human,isotype:IgG-scFv Anti-EGFR & Fc-gamma-RIIIA Reference Antibody (AFM24), Target:EGFR&Fc-gamma-RIIIA,Uniprot:P00533&P08637,Species:Human,isotype:IgG-scFv |
||
| A666743 |
| Anti-CD3e & DLL3 & Serum Albumin Reference Antibody (Hpn328), Target:CD3e&DLL3&SerumAlbumin,Uniprot:P07766&Q9NYJ7&P02768,Species:Human,isotype:BiTE Anti-CD3e & DLL3 & Serum Albumin Reference Antibody (Hpn328), Target:CD3e&DLL3&SerumAlbumin,Uniprot:P07766&Q9NYJ7&P02768,Species:Human,isotype:BiTE |
||
| A666742 |
| Anti-CD20 & CD47 Reference Antibody (Amulirafusp alfa), Target:CD20&CD47,Uniprot:P11836&P07766,Species:Human,isotype:IgG-FusionProtein Anti-CD20 & CD47 Reference Antibody (Amulirafusp alfa), Target:CD20&CD47,Uniprot:P11836&P07766,Species:Human,isotype:IgG-FusionProtein |
||
| A666741 |
| Anti-CTLA4 & PD-1 Reference Antibody (Volrustomig), Target:CTLA4&PD-1,Uniprot:P16410&Q15116,Species:Human,isotype:IgG-like Anti-CTLA4 & PD-1 Reference Antibody (Volrustomig), Target:CTLA4&PD-1,Uniprot:P16410&Q15116,Species:Human,isotype:IgG-like |
||
| A666740 |
| Anti-Ang2 & VEGFA Reference Antibody (Faricimab), Target:Angiopoietin2&VEGF-A,Uniprot:Q9UID3&P15692,Species:Human,isotype:IgG-like Anti-Ang2 & VEGFA Reference Antibody (Faricimab), Target:Angiopoietin2&VEGF-A,Uniprot:Q9UID3&P15692,Species:Human,isotype:IgG-like |
||
| A666739 |
| Anti-PD-1 & PD-L1 Reference Antibody (Reozalimab), Target:PD-1&PD-L1,Uniprot:Q15116&Q9NZQ7,Species:Human,isotype:IgG-like Anti-PD-1 & PD-L1 Reference Antibody (Reozalimab), Target:PD-1&PD-L1,Uniprot:Q15116&Q9NZQ7,Species:Human,isotype:IgG-like |
||
| A666738 |
| Anti-PD-1 & VEGF Reference Antibody (Ivonescimab), Target:PD-1&VEGF,Uniprot:Q15116&P15692,Species:Human,isotype:IgG-scFv Anti-PD-1 & VEGF Reference Antibody (Ivonescimab), Target:PD-1&VEGF,Uniprot:Q15116&P15692,Species:Human,isotype:IgG-scFv |
||
| A666737 |
| Anti-4-1BB & PD-L1 Reference Antibody (Acasunlimab), Target:4-1BB&PD-L1,Uniprot:Q07011&Q9NZQ7,Species:Human,isotype:IgG-like Anti-4-1BB & PD-L1 Reference Antibody (Acasunlimab), Target:4-1BB&PD-L1,Uniprot:Q07011&Q9NZQ7,Species:Human,isotype:IgG-like |
||
| A666736 |
| Anti-DLL4 & VEGF Reference Antibody (Navicixizumab), Target:DLL4&VEGF,Uniprot:Q9NR61&P15692,Species:Human,isotype:IgG-like Anti-DLL4 & VEGF Reference Antibody (Navicixizumab), Target:DLL4&VEGF,Uniprot:Q9NR61&P15692,Species:Human,isotype:IgG-like |
||
| A666735 |
| Anti-4-1BB & TPBG/5t4 Reference Antibody (Apv-527), Target:4-1BB&TPBG(5T4),Uniprot:Q07011&Q13641,Species:Human,isotype:ScFv-Fc-ScFv Anti-4-1BB & TPBG/5t4 Reference Antibody (Apv-527), Target:4-1BB&TPBG(5T4),Uniprot:Q07011&Q13641,Species:Human,isotype:ScFv-Fc-ScFv |
||
| A666734 |
| Anti-HER2/neu Reference Antibody (Zanidatamab), Target:HER2/neu,Uniprot:P04626,Species:Human,isotype:IgG-scFv Anti-HER2/neu Reference Antibody (Zanidatamab), Target:HER2/neu,Uniprot:P04626,Species:Human,isotype:IgG-scFv |
||
| A666733 |
| Anti-LAG-3 & PD-1 Reference Antibody (Tebotelimab), Target:LAG-3&PD-1,Uniprot:P18627&Q15116,Species:Human,isotype:DART-DART-Fc Anti-LAG-3 & PD-1 Reference Antibody (Tebotelimab), Target:LAG-3&PD-1,Uniprot:P18627&Q15116,Species:Human,isotype:DART-DART-Fc |
||
| A666732 |
| Anti-LAG-3 & PD-1 Reference Antibody (Emb-02), Target:LAG-3&PD-1,Uniprot:P18627&Q15116,Species:Human,isotype:Fab-IgG Anti-LAG-3 & PD-1 Reference Antibody (Emb-02), Target:LAG-3&PD-1,Uniprot:P18627&Q15116,Species:Human,isotype:Fab-IgG |